UF’s Rosenbloom recognized as distinguished endocrinologist

A University of Florida physician has won international recognition for his prominent role in shaping modern-day standards of care for children with diabetes or other endocrine disorders.

The Endocrine Society has selected Arlan Rosenbloom, M.D., a distinguished service professor emeritus of pediatrics at UF’s College of Medicine, to receive its 2003 Distinguished Physician Award for his outstanding contributions to the practice of clinical endocrinology. He will be presented the award, which includes a $3,000 honorarium, next June at the organization’s annual meeting in Philadelphia.

A pioneer in the field of pediatric endocrinology, Rosenbloom has been recognized throughout his career as a prominent educator, researcher and clinician. He has authored or co-authored more than 350 articles, chapters or books primarily on diabetes and growth problems—endocrine disorders he has studied extensively. His major research contributions include the first recognition that the body’s need for insulin increases through childhood and the demonstration of a latency period before the development of type 1 diabetes in children. He also was the first to describe limited joint mobility as a common early complication of childhood diabetes and its association with increased risk for long-term diabetes-related problems.

A member of the UF faculty since 1968, Rosenbloom established the department of pediatrics’ program in pediatric endocrinology and served as division chief until 1994. He developed the state-funded regional diabetes and endocrine program and Florida’s Camp for Children and Youth with Diabetes. He was founding director of the UF College of Medicine’s Diabetes Center and directed the National Institutes of Health-funded General Clinical Research Center at UF.